Skip to main content
Premium Trial:

Request an Annual Quote

Horizon Discovery, ATCC Sign Distribution Deal for Cell Lines

NEW YORK (GenomeWeb News) – Horizon Discover today said it has signed a licensing and distribution deal with the American Type Culture Collection for certain sets of panels of X-Man isogenic cell lines.

ATCC will provide to its academic and not-for-profit customers certain Horizon products as part of, or in conjunction with, ATCC's Tumor Cell Panels. The deal is for non-commercial use only and excludes distribution in Japan or distribution of X-Man isogenic cell lines in isolation.

Financial and other terms of the deal were not disclosed.

Horizon offers more than 450 X-Man cell lines, which it said are the world's first source of genetically defined and patient-relevant human cell lines.

"The ability to work with accurate disease model cell lines is of great benefit, particularly in oncology research where many mutations studied are rare, and reliable sources of patient-derived cell lines are scarce," ATCC CEO Raymond Cypess said in a statement.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.